To read more on this topic click here.
Scottish university reveals multimillion-pound Parkinson’s research partnership
News
Author: Roisin McCormackPublished: 10 July 2019
Prep:
Cook:
Serves:

The University of Dundee, UK, has announced a collaboration with South Korean pharmaceutical company Bukwang to develop a new treatment for Parkinson’s.
Collaborating with researchers at the University of Oxford, UK, the university’s drug discovery unit (DDU) has found molecules that may reduce levels of a protein closely connected to the development of the condition.
The new partnership will build on this existing relationship between the universities – and facilitate a further three-year Parkinson’s research programme which will move the molecules towards clinical development.
Professor Paul Wyatt, head of the DDU, said: “Drug discovery for neurological disorders is especially challenging and an area where academia and industry need to be working together.
“This project brings together the clinical and translational research expertise in Oxford with Dundee’s professional drug-discovery capabilities, allowing us to move one stage further towards a treatment.”
Read more:
Parkinson’s may originate in the gut, says new study
Acupuncture may alleviate Parkinson’s symptoms
Last Month
Next Month
Share this story
Related articles

Interviews
Dance craze turned Parkinson’s app: the story behind Patana AI
The app helps diagnose people with Parkinson’s
READ MORE
Global update
Seven must-see movies about Parkinson’s
A handpicked Parkinson’s movie watchlist
READ MORE
PD in Practice
6 tips for improving speech in Parkinson’s
How to get the most from speech therapy sessions with PwPs
READ MORE
Comments